These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289 [TBL] [Abstract][Full Text] [Related]
4. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Ramondetta L; Mills GB; Burke TW; Wolf JK Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365 [TBL] [Abstract][Full Text] [Related]
7. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
10. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969 [TBL] [Abstract][Full Text] [Related]
11. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521 [TBL] [Abstract][Full Text] [Related]
14. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Vikhanskaya F; Erba E; D'Incalci M; Broggini M Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577 [TBL] [Abstract][Full Text] [Related]
15. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432 [TBL] [Abstract][Full Text] [Related]
16. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related]
17. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078 [TBL] [Abstract][Full Text] [Related]
18. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184 [TBL] [Abstract][Full Text] [Related]
19. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein]. Li Y; Mi C Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas. Song K; Li Z; Seth P; Cowan KH; Sinha BK Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]